Skip to content
StockMarketAgent
Industrials / ConglomeratesUpdated 2026-05-10 22:07 UTC

HHS stock hub

Harte Hanks, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HHSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
20.9M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
HHS
In the news

Latest news · HHS

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 14.6P50 20.6P75 30.4
Trailing P/En/a
P25 17.1P50 27.2P75 47.6
ROE-3.8
P25 -16.4P50 5.9P75 16.4
ROIC2.7
P25 -10.3P50 5.1P75 12.2
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HHS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
213
Groups with data
11
Currency
USD
Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0000045919
Company name
Harte Hanks, Inc.
Country
United States
Country code
US
Cusip
416196202
Employees
2,069
Employees Change
66%
Employees Change Percent
3.3
Enterprise value
$37.7M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Conglomerates
Isin
US4161962026
Last refreshed
2026-05-10
Market cap
$20.9M
Market cap category
Nano-Cap
Price
$2.82
Price currency
USD
Rev Per Employee
77,124.21x
Sector
Industrials
Sic
7331
Symbol
HHS
Website
https://www.hartehanks.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-3.88%
EV/EBIT
39.14x
EV/EBITDA
6.94x
EV/Sales
0.24x
FCF yield
-21.48%
P/B ratio
1.02x
P/S ratio
0.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
0.6%
EBITDA Margin
3.41%
Gross margin
17.32%
Gross Profit
$27.6M
Gross Profit Growth Q
-22.21%
Gross Profit Growth3 Y
-9.81%
Gross Profit Growth5 Y
6.34%
Net Income
$-811,000
Net Income Growth Quarters
1%
Net Income Growth Years
1%
Pretax Margin
-0.63%
Profit Margin
-0.51%
Profit Per Employee
$-392
ROA
0.62
Roa5y
-0.12
ROCE
1.56
ROE
-3.84
ROIC
2.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr10y
-16.49%
Cagr15y
-19.13%
Cagr1y
-41.38%
Cagr20y
-18.9%
Cagr3y
-22.55%
Cagr5y
-11.38%
EPS Growth Quarters
1
EPS Growth Years
1
OCF Growth Q
-81.78%
Revenue Growth
-13.86x
Revenue Growth Q
-15.43x
Revenue Growth Years
0x
Revenue Growth3 Y
-8.2x
Revenue Growth5 Y
-2.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
$1.65
Assets
$91.8M
Cash
$5.6M
Current Assets
$46.3M
Current Liabilities
$30.2M
Debt
$22.4M
Debt EBITDA
$1.86
Debt Equity
$1.09
Equity
$20.5M
Interest Coverage
3.89
Liabilities
$71.3M
Long Term Assets
$45.5M
Long Term Liabilities
$41.1M
Net Cash
$-16.8M
Net Cash By Market Cap
$-80.43
Net Debt EBITDA
$3.09
Net Debt Equity
$0.82
Tangible Book Value
$19.9M
Tangible Book Value Per Share
$2.68
WACC
2.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.54
Net Working Capital
$14.1M
Quick ratio
1.34
Working Capital
$16.2M
Working Capital Turnover
$9.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

4
MetricValue
Buyback Yield
-1.37%
Dividend per share
$0
Dividend Yield
0%
Last Dividend
$0.85

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-83.51%
1Y total return
-41.36%
200-day SMA
3.16
3Y total return
-53.54%
50-day SMA
2.68
50-day SMA vs 200-day SMA
50under200
5Y total return
-45.35%
All Time High
314.7
All Time High Change
-99.1%
All Time High Date
2005-06-20
All Time Low
1.1
All Time Low Change
156.36%
All Time Low Date
2020-04-03
ATR
0.14
Beta
-0.03
Beta1y
1.62
Beta2y
0.74
Ch YTD
-6.31
High
2.83
High52
5.39
High52 Date
2025-06-23
High52ch
-47.68%
Low
2.74
Low52
2.22
Low52 Date
2026-03-30
Low52ch
27.03%
Ma50ch
5.26%
Price vs 200-day SMA
-10.65%
RSI
55.77
RSI Monthly
35.55
RSI Weekly
45.32
Sharpe ratio
-0.8x
Sortino ratio
-1.05
Total Return
-1.37%
Tr YTD
-6.31
Tr15y
-95.87%
Tr1m
12.8%
Tr1w
2.92%
Tr3m
-3.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
$964,000
Operating Income Growth3 Y
-58.06
Operating margin
0.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
3,296,399%
Float Percent
44.46%
Net Borrowing
-159,000
Shares Insiders
38.17%
Shares Institutions
23.32%
Shares Out
7,414,794
Shares Qo Q
0%
Shares Yo Y
1.37%
Short Float
1.69%
Short Ratio
3.12
Short Shares
0.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

68
MetricValue
Adjusted FCF
$-4.8M
Average Volume
20,017x
Bv Per Share
2.77
CAPEX
$-2.8M
Ch10y
-83.51
Ch15y
-96.83
Ch1m
12.8
Ch1w
2.92
Ch1y
-41.36
Ch20y
-98.97
Ch3m
-3.75
Ch3y
-53.54
Ch5y
-45.35
Ch6m
1.81
Change
1.44%
Change From Open
2.55
Close
2.78
Days Gap
-1.08
Depreciation Amortization
4,472,000
Dollar Volume
37,178.9
Earnings Date
2026-05-14
Earnings Time
amc
EBIT
$964,000
EBITDA
$5.4M
EPS
$-0.11
F Score
3
FCF
$-4.5M
FCF EV Yield
-11.91x
FCF Per Share
$-0.61
Financing CF
514,000
Fiscal Year End
December
Founded
1,923
Goodwill
295,000
Income Tax
$-197,000
Investing CF
-2,756,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-17
Last Report Date
2025-12-31
Last Split Date
2018-02-01
Last Split Type
Reverse
Last10k Filing Date
2026-03-17
Ma150
3.02
Ma150ch
-6.5%
Ma20
2.78
Ma20ch
1.62%
Net CF
-4,347,000
Next Earnings Date
2026-05-22
Open
2.75
Optionable
No
Position In Range
88.89
Post Close
2.82
Postmarket Change Percent
1.77
Postmarket Price
$2.87
Ppne
28,240,000
Price Date
2026-05-08
Price EBITDA
$3.85
Ptbv Ratio
1.05
Relative Volume
0.66x
Revenue
159,570,000x
SBC By Revenue
0.16x
Share Based Comp
258,000
Tax By Revenue
-0.12x
Tr20y
-98.49%
Tr6m
1.81%
Us State
Massachusetts
Volume
13,184
Z Score
14.64
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HHS pay a dividend?

Capital-return profile for this ticker.

Performance

HHS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-41.4%
S&P 500 1Y: n/a
3Y total return
-53.5%
S&P 500 3Y: n/a
5Y total return
-45.3%
S&P 500 5Y: n/a
10Y total return
-83.5%
S&P 500 10Y: n/a
Ownership

Who owns HHS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+23.3%
Float: +44.5% of shares outstanding
Insider ownership
+38.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+1.7%
3.1 days to cover
Y/Y dilution
+1.4%
Negative means the company is buying back shares.
Technical

HHS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.8
Neutral momentum band
Price vs 200-day MA
-10.6%
50/200-day relationship not available
Beta (5Y)
-0.03
Less volatile than the market
Sharpe ratio
-0.80
Risk-adjusted return — higher is better; >1.0 is solid.
Peers

HHS vs. sector cohort

Currency-neutral comparison: P/E, P/S, ROIC, 5Y revenue CAGR, and 1Y total return. Market-cap column appears only when every peer reports in the same currency.

TickerNameMarket capP/EP/SROIC5Y rev CAGR1Y total returnRating
BAThe Boeing Company187.1B95.1x2.0x-13.6%+10.3%+27.9%बेचें
CATCaterpillar Inc.413.4B44.7x5.8x16.5%+10.5%+183.2%बेचें
DEDeere & Company155.3B32.4x3.3x6.0%+4.8%+23.3%बेचें
Questions

About HHS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HHS stock rating?

Harte Hanks, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HHS analysis?

The full report lives at /stocks/HHS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HHS?

The latest report frames HHS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HHS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.